What makes health care a different transaction from any other sale of a product? Why should we care about the interaction between the "supplier" and "consumer" and whether the consumer is treated fairly? The delivery of health care is bound within legal and economic restraints that should protect the interests of the consumer and of the provider. Yet health care is a unique economic good on several levels: information is asymmetrical, and third parties such as payers and utilization review committees influence decision-making and access. 1, 2 The uniqueness of health care should make us view the transaction between the patient and the provider carefully, because the patient does not come into the relationship at arms length, with equal power to that of the provider. Therefore, the patient is placed in a vulnerable position in which he or she must trust that the provider will do what is in the patient's best interest. 3, 4 We can hypothesize that a person's past experiences influences that person's level of trust. Negative experiences result in a lower level of trust. A patient who has experienced racism or discrimination from individuals and institutions would be less willing to be vulnerable and place trust in a system of unknowns such as medical care. Recent analyses of the relationships of minority patients with their physicians have demonstrated that provider racism and patient awareness of invidious past events such as the experimentation on slaves and the Tuskegee syphilis experiment have contributed to minority patients having less access to and knowledge of specific medical treatments than their white counterparts, 5-10 lower levels of trust, and greater unwillingness to participate in clinical trials. 3, [11] [12] [13] This places minority patients at a disadvantage not only in receiving preventive care but also in access to newer technology and treatment stemming from clinical trials. However, as Boulware et al. point out, 14 prior analyses have not fully addressed minority patients' attitudes toward components of the health care system.
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Past solutions such as cultural competence curricula, sensitivity training, the presence of interpreters, and increasing the number of minority physicians may not fully address the problem, however, if racism and discrimination in the health care system goes beyond the patient-physician relationship. Yet these solutions may be adaptable in order to change hospital and system policy. Additional solutions such as the recruitment of minority health care administrators and executives and the presence of a community advisory board that represents the demography of the catchment area served could also foreseeably change the perception of African American patients. Regaining the trust of the African American patient at all points of entry to the health care system is imperative if we are to reduce health disparities.
